Illumina, Inc. (ILMN) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 39.95B USD. 52-week range 88.00 to 309.35 USD. Trailing P/E 49.4. Data as of 2026-10-09.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other ...